Skip to main content

Want a detailed portfolio tracker?

Lantern Pharma (LTRN) P/E (2020 - 2026)

Lantern Pharma (LTRN) P/E from Jun 11, 2020 to Jul 20, 2026. The TTM Lantern Pharma (LTRN) P/E is -2.05. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Lantern Pharma (LTRN)

YearP/EChange
2026-2.05+5.83%
2025-1.94+17.31%
2024-1.65-46.11%
2023-3.07-32.85%
2022-4.57-36.59%
2021-7.20-54.47%
2020-15.82N/A

Comparison Lantern Pharma (LTRN) P/E with competitors

Lantern Pharma (LTRN) P/E is -2.05.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.08%
NBYStablecoin Development Corp0.00-100.21%
ENLVEnlivex Ltd0.07-103.65%
FGENFibroGen Inc0.24-111.70%
CHRSCoherus Biosciences Inc0.85-141.35%
FBIOFortress Biotech Inc0.95-146.25%
ORMPOramed Pharmaceuticals Inc1.50-173.25%
AGENAgenus Inc3.01-246.66%
INVAInnoviva Inc3.15-253.70%
VXRTVaxart Inc3.55-272.98%
CRMDCorMedix Inc3.63-276.82%
CVACCureVac N.V.4.45-316.64%
GLPGGalapagos NV4.86-336.78%
SRPTSarepta Therapeutics Inc4.88-337.91%
ABEOAbeona Therapeutics Inc5.39-362.54%
ABUSArbutus Biopharma Corp5.60-372.68%
ZVRAZevra Therapeutics Inc5.89-386.89%
SPROSpero Therapeutics Inc6.23-403.52%
CGENCompugen Ltd6.31-407.68%
RIGLRigel Pharmaceuticals6.87-434.88%
SLXNSilexion Therapeutics Corp7.30-455.54%
OMEROmeros Corporation9.26-551.19%
AUPHAurinia Pharmaceuticals Inc9.58-567.08%
PLXProtalix BioTherapeutics Inc10.89-630.73%
ACADAcadia Pharmaceuticals Inc11.73-671.54%
TBPHTheravance Biopharma Inc12.26-697.54%
ADMAAdma Biologics Inc12.42-705.15%
HRMYHarmony Biosciences Holdings Inc13.82-773.47%
SABSSAB Biotherapeutics Inc14.14-788.87%
NAGENiagen Bioscience Inc14.82-822.10%
INCYIncyte Corp15.82-871.05%
REGNRegeneron Pharmaceuticals Inc15.86-872.71%
PBYIPuma Biotechnology Inc17.32-943.81%
CPRXCatalyst Pharmaceuticals Inc17.44-949.83%
EXELExelixis Inc17.54-954.64%
TGTXTG Therapeutics Inc18.97-1024.23%
MDXGMimedx Group Inc20.55-1101.54%
XOMAXOMA Royalty Corp22.87-1214.73%
ARGXArgen X SE24.30-1284.10%
CTMXCytomX Therapeutics Inc24.82-1309.59%
XOMAOXOMA Royalty Corp25.34-1335.11%
HALOHalozyme Therapeutics Inc25.62-1348.70%
XOMAPXOMA Royalty Corp25.67-1350.96%
VRTXVertex Pharmaceuticals Inc27.99-1464.25%
RPRXRoyalty Pharma plc - Class A28.69-1498.01%
SLNOSoleno Therapeutics Inc29.02-1513.98%
ASNDAscendis Pharma A/S30.09-1566.14%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1947.54%
APLSApellis Pharmaceuticals Inc39.02-2001.59%
BMRNBiomarin Pharmaceutical Inc42.21-2157.08%
KRYSKrystal Biotech Inc45.34-2309.69%
ONCBeiGene Ltd69.54-3488.86%
PHARPharming Group N.V.75.03-3756.17%
TECHBio-Techne Corp101.96-5068.66%
VCELVericel Corp109.92-5456.72%
ALNYAlnylam Pharmaceuticals Inc117.96-5848.71%
GMABGenmab140.29-6936.69%
TLXTelix Pharmaceuticals Ltd162.15-8002.07%
CORTCorcept Therapeutics Inc212.86-10473.03%